U.S. Markets closed

ThromboGenics NV (TBGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.800.00 (0.00%)
At close: 9:31AM EDT
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue7,00011,00014,000113,000
Cost of Revenue7,0003,0005,0006,000
Gross Profit-8,0009,000106,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses41,00050,00066,00087,000
Operating Income or Loss-34,000-39,000-53,00026,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-34,000-39,000-53,00026,000
Interest Expense----
Income Before Tax----
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-60,000-38,000-51,00026,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----